NRX Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Wilmington, DE
NRXP chart
What traders are saying about $NRXP
Latest postsNRX Pharmaceuticals, Inc. news
- NRx Clears Manufacturing Hurdle for Ketamine FDA Review
MyChesCo ·
- NRx Pharmaceuticals says NY Times retracts ‘false statements’ about NRx
TipRanks ·
- NRX Pharmaceuticals, Inc. Estimates – NASDAQ:NRXP
TradingView ·
- NRx Pharmaceuticals calls NY Times report ‘knowingly false,’ demands retraction
TipRanks ·
- Ketamine drugmakers seek FDA approval as providers raise concerns: 5 things to know
RamaOnHealthcare ·
- NRx Nears FDA Decision on U.S.-Made Ketamine Product
MyChesCo ·
- Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Yahoo Finance ·
- NRx Pharmaceuticals (Nasdaq:NRXP) Announces Completion of Manufacturing Process Validation and Two-Year Stability of Preservative-Free Ketamine
Yahoo Finance ·
- NRx Pharmaceuticals Announces Receipt of FDA Labeling Review Letter for Preservative-Free Ketamine
Yahoo Finance ·
- NRx Defense Systems, an NRx Company (Nasdaq:NRXP) Awarded $11 Million Dollar DARPA Prime Contract to Evaluate Robotic Magnetic Stimulation in conjunction with NRX-101 for Treatment of Resistant Depression
Yahoo Finance ·
- Ono Pharmaceutical Co. (OPHLF) Soars 13.9%: Is Further Upside Left in the Stock?
Yahoo Finance ·
- NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine
Yahoo Finance ·
NRX Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.2M | $0 | – | – |
| Net income | -$28.6M | -$25.1M | -$30.1M | -$39.8M |
| Diluted EPS | – | – | – | $-0.60 |
| Total assets (year end) | $13.0M | $3.7M | $7.3M | $25.8M |
| Cash and equivalents (year end) | $7.8M | $1.4M | $4.6M | $20.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About NRX Pharmaceuticals, Inc.
- Ticker
- NRXP (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Wilmington, DE
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1719406
- Former names
- Big Rock Partners Acquisition Corp.
Frequently asked questions
What exchange is NRX Pharmaceuticals, Inc. listed on?
NRX Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol NRXP.
What industry is NRX Pharmaceuticals, Inc. in?
NRX Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is NRX Pharmaceuticals, Inc. headquartered?
NRX Pharmaceuticals, Inc.'s business address on file with the SEC is in Wilmington, DE.
When does NRX Pharmaceuticals, Inc.'s fiscal year end?
NRX Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did NRX Pharmaceuticals, Inc. report?
NRX Pharmaceuticals, Inc. reported $1.2M in revenue for calendar year 2025, according to its SEC filings.